Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort study.

Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort study.
复制标题

DOI:
10.1038/s41598-022-26606-z
复制
发表时间:
2023-01-04
期刊:
影响因子:
4.6
通讯作者:
--
中科院分区:
综合性期刊3区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

先兆子痫与产后心功能障碍有关;然而,这种关系的性质仍不确定。这项多中心回顾性队列研究旨在确定预先存在心功能不全(左心室射血分数< 55%)的女性中先兆子痫的患病率,并探讨妊娠结局与孕前心脏表型之间的关系。在该282例妊娠队列中,先兆子痫患病率没有显著增加(4.6% [95% C.I. 2.2-7.0%] vs.人群患病率4.6% [95% C.I. 2.2-7.0%])。2.7-8.2],p = 0.99); 12/13名妇女同时存在先兆子痫的产科/医学风险因素。早产先兆子痫(< 37周)和胎儿生长受限(FGR)的患病率增加(分别为1.8% vs. 0.7%,p = 0.03; 15.2% vs. 5.5%,p < 0.001)。收缩和舒张功能均与妊娠结局无关。胎儿生长阻滞剂(n = 116)与出生体重Z评分较低相关(校正差异为-0.31 [95% C.I. -0.61至-0.01],p = 0.04)。总之,这项研究表明,在预先存在心功能不全的妇女中,早产先兆子痫的发病率适度增加,FGR显著增加。我们的研究结果不一定支持心功能不全和先兆子痫之间的因果关系,特别是考虑到人群的背景风险状态。心功能不全和FGR之间关系的机制值得进一步研究,但可能受到同时使用β受体阻滞剂的影响。
Pre-eclampsia is associated with postnatal cardiac dysfunction; however, the nature of this relationship remains uncertain. This multicentre retrospective cohort study aimed to determine the prevalence of pre-eclampsia in women with pre-existing cardiac dysfunction (left ventricular ejection fraction < 55%) and explore the relationship between pregnancy outcome and pre-pregnancy cardiac phenotype. In this cohort of 282 pregnancies, pre-eclampsia prevalence was not significantly increased (4.6% [95% C.I 2.2–7.0%] vs. population prevalence of 4.6% [95% C.I. 2.7–8.2], p = 0.99); 12/13 women had concurrent obstetric/medical risk factors for pre-eclampsia. The prevalence of preterm pre-eclampsia (< 37 weeks) and fetal growth restriction (FGR) was increased (1.8% vs. 0.7%, p = 0.03; 15.2% vs. 5.5%, p < 0.001, respectively). Neither systolic nor diastolic function correlated with pregnancy outcome. Antenatal ß blockers (n = 116) were associated with lower birthweight Z score (adjusted difference − 0.31 [95% C.I. − 0.61 to − 0.01], p = 0.04). To conclude, this study demonstrated a modest increase in preterm pre-eclampsia and significant increase in FGR in women with pre-existing cardiac dysfunction. Our results do not necessarily support a causal relationship between cardiac dysfunction and pre-eclampsia, especially given the population’s background risk status. The mechanism underpinning the relationship between cardiac dysfunction and FGR merits further research but could be influenced by concomitant ß blocker use.
DOI: 10.1001/jamacardio.2017.0283
发表时间: 2017-06-01
期刊: JAMA CARDIOLOGY
影响因子: 24
作者:
Hayward, Robert M.;Foster, Elyse;Tseng, Zian H.
通讯作者: Tseng, Zian H.
DOI: 10.1161/hypertensionaha.111.173278
发表时间: 2011-07-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Evans, Caroline S.;Gooch, Linda;Shroff, Sanjeev G.
通讯作者: Shroff, Sanjeev G.
DOI: 10.1136/heartjnl-2016-309671
发表时间: 2017-02-01
期刊: HEART
影响因子: 5.7
作者:
Auger, Nathalie;Fraser, William D.;Paradis, Gilles
通讯作者: Paradis, Gilles
DOI: 10.1016/s0029-7844(98)00522-5
发表时间: 1999-05-01
影响因子: 7.2
作者:
Easterling, TR;Brateng, D;Millard, SP
通讯作者: Millard, SP
DOI: 10.1111/1471-0528.12522
发表时间: 2014-04-01
影响因子: 5.8
作者:
Ersboll, A. S.;Hedegaard, M.;Johansen, M.
通讯作者: Johansen, M.